A Single-blind, Randomized, Placebo-controlled Phase I Study to assess the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Multiple Oral Doses of AZD6140 in Healthy Male Japanese and Caucasian Subjects

Study identifier:D5130C05267

ClinicalTrials.gov identifier:N/A

EudraCT identifier:N/A

CTIS identifier:N/A

Study Complete

Official Title

Medical condition

Phase

Healthy volunteers

Study drug

Sex

Actual Enrollment

Study type

Interventional

Age

Date

Study Start Date: 01 Jun 2003

Primary Completion Date: -

Study Completion Date: -

Study design

Allocation: -
Endpoint Classification: -
Intervention Model: -
Masking: -
Primary Purpose: -

Verification:

Verified 01 May 2014 by AstraZeneca

Collaborators

Inclusion and exclusion criteria

No locations available

Arms	Assigned Interventions

Documents available

D5130C05267_CSP_Redacted
Download
Trial Results Summaries
Available here